Who owns PRAX?
Institutional ownership of Praxis Precision Medicines Inc. from Form 13F, Q2 2026
309 institutional managers reported holding Praxis Precision Medicines Inc. (PRAX) in Form 13F filings for Q2 2026, with 33,719,938 shares worth $11.3B. The largest reported holder was Jupiter Topco LLC. Managers that filed both quarters added a net 1,901,398 shares (+6.7%). 57 opened new positions and 38 sold out.
- Funds holding
- 309
- Value held
- $11.3B
- New / sold out
- 57 / 38
- Net shares, same filers
- +6.7%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of PRAX
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Jupiter Topco LLC | $1.1B | 10.1% | 3,421,374 | First report |
| FMR LLC | $776M | 6.9% | 2,316,907 | Added |
| BlackRock, Inc. | $768M | 6.8% | 2,292,585 | Trimmed |
| Perceptive Advisors LLC | $682M | 6.0% | 2,035,986 | Unchanged |
| Baker Bros. Advisors LP | $587M | 5.2% | 1,753,198 | Unchanged |
| Orbis Allan Gray Ltd | $512M | 4.5% | 1,529,788 | Trimmed |
| Vanguard Portfolio Management LLC | $447M | 4.0% | 1,335,185 | Added |
| Vanguard Capital Management LLC | $414M | 3.7% | 1,235,299 | Added |
| State Street Corp | $344M | 3.0% | 1,026,443 | Added |
| Adage Capital Partners GP, L.l.c. | $340M | 3.0% | 1,015,480 | Added |
| Deerfield Management Company, L.p. | $323M | 2.9% | 963,351 | Unchanged |
| Driehaus Capital Management LLC | $321M | 2.8% | 959,048 | Added |
| Price T Rowe Associates Inc | $316M | 2.8% | 942,999 | Added |
| Morgan Stanley | $286M | 2.5% | 854,112 | Added |
| Geode Capital Management, LLC | $250M | 2.2% | 748,039 | Added |
| Cormorant Asset Management, LP | $214M | 1.9% | 640,000 | Trimmed |
| Goldman Sachs Group Inc | $184M | 1.6% | 548,830 | Trimmed |
| Bank of America Corp | $183M | 1.6% | 546,930 | Added |
| Invesco Ltd. | $180M | 1.6% | 537,548 | Added |
| Hood River Capital Management LLC | $142M | 1.3% | 425,167 | Added |
| Norges Bank | $116M | 1.0% | 346,969 | New |
| Franklin Resources Inc | $110M | 1.0% | 327,124 | Added |
| Pictet Asset Management Holding SA | $98.0M | 0.9% | 291,689 | Added |
| Polar Capital Holdings Plc | $93.5M | 0.8% | 279,131 | New |
| Vivo Capital, LLC | $90.8M | 0.8% | 271,116 | Trimmed |
Share of 13F holdings is each fund's shares as a share of the 33,719,938 PRAX shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Vanguard Portfolio Management LLC Added+$194M
- Invesco Ltd. Added+$159M
- Norges Bank New+$116M
- Price T Rowe Associates Inc Added+$105M
- Polar Capital Holdings Plc New+$93.5M
- Westfield Capital Management Co LP Added+$73.1M
- Adage Capital Partners GP, L.l.c. Added+$66.9M
- FMR LLC Added+$52.2M
- State Street Corp Added+$47.6M
- American Century Companies Inc Added+$36.5M
Biggest sellers in Q2 2026
- Orbis Allan Gray Ltd Trimmed-$316M
- Ra Capital Management, L.p. Sold out-$120M
- Cormorant Asset Management, LP Trimmed-$82.2M
- Goldman Sachs Group Inc Trimmed-$54.2M
- Soleus Capital Management, L.P. Trimmed-$51.2M
- Stempoint Capital LP Trimmed-$25.2M
- ArrowMark Colorado Holdings LLC Trimmed-$24.0M
- Vivo Capital, LLC Trimmed-$22.7M
- Sofinnova Investments, Inc. Trimmed-$19.2M
- Wellington Management Group LLP Trimmed-$16.2M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $1.5B and sold $886M; 120 added and 93 trimmed.
Schedule 13D and 13G filings on PRAX
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-05-15BAKER BROS. ADVISORS LP SCHEDULE 13G filed by Praxis Precision Medicines Inc.Schedule 13G
- 2026-02-17ORBIS INVESTMENT MANAGEMENT LTD SCHEDULE 13G filed by Praxis Precision Medicines Inc.Schedule 13G
- 2026-02-05FMR LLC SCHEDULE 13G filed by Praxis Precision Medicines Inc.Schedule 13G
- 2025-07-22PERCEPTIVE ADVISORS LLC SCHEDULE 13G filed by Praxis Precision Medicines Inc.Schedule 13G
- 2025-05-14JANUS HENDERSON GROUP PLC SCHEDULE 13G filed by Praxis Precision Medicines Inc.Schedule 13G
- 2025-05-12Adage Capital Management, L.P. SCHEDULE 13G filed by Praxis Precision Medicines Inc.Schedule 13G
- 2025-02-05MORGAN STANLEY SCHEDULE 13G filed by Praxis Precision Medicines Inc.Schedule 13G
Questions about PRAX ownership
- Who owns PRAX stock?
- 309 institutional investment managers reported PRAX positions in their Form 13F filings for Q2 2026, holding 33,719,938 shares worth $11.3B in total. Jupiter Topco LLC reported the largest position.
- Are funds buying or selling PRAX?
- In Q2 2026, 57 managers opened new PRAX positions, 120 added, 93 trimmed and 38 sold out. Managers that filed in both quarters added a net 1,901,398 shares.
- How current is this PRAX institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to PRAX by CUSIP. Options are left out. PRAX news and filings · PRAX insider trades · Top funds